Aurinia Pharmaceuticals(AUPH) - 2025 Q2 - Quarterly Report
Aurinia Pharmaceuticals(US:AUPH)2025-07-31 10:10☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q _____________________________________________ x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR (250) 744-2487 Registrant's telephone number, including area code _____________________________________________ Indicate by check mark whether the registrant ...